Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by lscfaon Dec 10, 2020 5:16pm
155 Views
Post# 32082256

RE:RE:Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role,

RE:RE:Medipharm Labs Sees CEO Pat McCutcheon Step Down From Role,

 

Capital expend.

MediPharm

Valens

Radient

Q3 20

1,004

9,171

669

Q2 20 

2,919

5,609

0

Q1 20

3,490

6,507

894

Q4 19

9,463

3,659

785

Q3 19 

10,799

1,936

6,322

Q2 19

5,679

11,898

3,066

Q1 19

6,497

2,738

2,095

Q4 18

3,439

865

3,251

Q3 18

8,488

575

3,508

Q2 18

323

2,376

3,442

Q1 18

2,322

1,861

564

 

54,423

47,195

24,596

 




lscfa wrote: Radient Energy CEO recently sacked too. Both bozos kept growth plans going when there were clear signs market was slowing (e.g. slow rollout of retail in ont/que, no vapes in que) 

 

<< Previous
Bullboard Posts
Next >>